Indication*

For the management of: Renal tubular acidosis (RTA) with calcium stones; Hypocitraturic calcium oxalate nephrolithiasis of any etiology; Uric acid lithiasis with or without calcium stones. For the prevention of stone relapse after extracorporeal shock wave lithotripsy (ESWL) or lithotomy.

Directions for Use*

General Dosing Recommendations: Potassium citrate extended-release preparation. The tablet should be swallowed whole, not crushed, chewed or sucked to prevent premature release of active ingredient. Take the tablet 30 minutes after meals. Limit salt intake by avoiding food with high salt content while on potassium citrate therapy. Increase fluid intake. Urine volume should be at least two liters per day. Adult Dose: Severe Hypocitraturia (urinary citrate <150 mg/day); Orally, 60 mEq/day taken in two or three divided doses (30 mEq two times/day or 20 mEq three/day). Mild to moderate Hypocitraturia (urinary citrate >150 mg/day); Orally mEq/day taken in two or three divided doses (15 mEq two times/day or 10 mEq three times/day). Or, as prescribed by a physician.

Administration*

Should be taken with food: Take 30 min after meals. Swallow whole, do not crush/chew/suck.

*written indications, directions, and administration are updated as of February 26, 2025 and may not be accurate with the actual product purchased. Please read the details in the packaging.

Share

Share

Link

Close share Copy link

View full details